[1]
R. BISHT, “SODIUM-GLUCOSE LINKED COTRANSPORTER 2 INHIBITOR: A NEW HORIZON IN THE TREATMENT OF TYPE-2 DIABETES”, Asian J Pharm Clin Res, vol. 14, no. 3, pp. 45-48, Mar. 2021.